Publications

5674 Results

Long-term survival on S0033: a phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs)

Authors
C Blanke;C Rankin;R Benjamin;AK Raymond;M Heinrich;C Fletcher;J Crowley;EC Borden;G Demetri;L Baker
Journal / Conference
Proc ESMO 47:S664 2011 (abstr 9404) (European Society for Medical Oncology Annual Meeting, oral)
Year
2011
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 [PMID21135270; PMC3056462]

Authors
E Gore;S Wong;A Sun;JA Bonner;SC Schild;L Gaspar;JA Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):272-278
Year
2011
Research Committee(s)
Lung

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. [PMID21135267; PMC3056463]

Authors
A Sun;K Bae;B Movsas;S Wong;CA Meyers;JA Bonner;SE Schild;L Gaspar;J Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):279-286
Year
2011
Research Committee(s)
Lung

A phase III randomized trial of anastrozole versus anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;D Lew;D Hayes;J Gralow;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abst. S1-1;oral presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0226

SWOG S0927: A randomized doubled blind placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor (AI)-induced musculoskeletal pain in women with early stage breast cancer

Authors
D Hershman;J Unger;K Crew;C Moinpour;L Minasian;L Hansen;D Lew;K Kaberle;J Wade;F Meyskens
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract OT2-07-02 (poster);
Year
2011
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927

A randomized phase III clinical trial of standard adjuvant endocrine therapy in patients (pts) with 1-3 positive nodes, hormone receptor (HR)-positive and HER-2negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
A Gonzalez-Angulo;W Barlow;J Gralow;F Meric-Bernstam;D Hayes;C Moinpour;S Ramsey;A Schott;D Sparks;K Albain;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract # OT1-03-01;poster presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation [PMID21680797;PMC3156042]

Authors
M Fang;B Storer;E Estey;M Othus;L Zhang;B Sandmaier;F Appelbaum
Journal / Conference
Blood 118(6):1490-1494
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9126, SWOG-9333, SWOG-9500

Cytarabine dose for acute myeloid leukemia. (Letter to the Editor) [PMID21631340]

Authors
B Medeiros;M Othus;F Appelbaum
Journal / Conference
New England Journal of Medicine 364(11):2167-2168
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

A phase III randomized intergroup trial (SWOG S0016) of CHOP chemotherapy plus rituximab vs. CHOP chemotherapy plus iodine-131 for the treatment of newly diagnosed follicular non- hodgkin's lymphoma

Authors
O Press;J Unger;L Rimsza;J Friedberg;M Leblanc;M Czuczman;M Kaminski;R Braziel;D Maloney;B Cheson;TP Miller;RI Fisher
Journal / Conference
Blood 118:abstract 98; American Society of Hematology Annual Meeting, oral
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Prognostic significance of FLT3 and NPM1 mutations in adults of age 18-60 with de novo acute myeloid leukemia (AML): a study by FHCRC and SWOG

Authors
EL Pogosova-Agadjanyan;K Kopecky;S Petersdorf;H Erba;RM Stone;S Mehinchi;TJ Nevill;J Radich;L Stenke;M Slovak;RK Stuart;M Tallman;C Willman;A Brumbaugh;M Cronk;C Cummings;J Engel;R Mortensen;A Suchanek;F Appelbaum;D Stirewalt
Journal / Conference
Blood 118(21):abst 2520; American Society of Hematology Annual Meeting, poster presentation;
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106